Search for: "Anda Pharmaceuticals, Inc"
Results 261 - 280
of 605
Sort by Relevance
|
Sort by Date
18 Jan 2013, 2:06 pm
The Decherts are too involved in this litigation to comment publicly.There aren’t many research-oriented pharmaceutical companies based in Alabama, and after last week’s execrable decision in Wyeth, Inc. v. [read post]
13 Jan 2013, 9:06 pm
• Defendants: Apotex Inc.; Apotex Corp.; Sandoz, Inc.; Hi-Tech Pharmacal Co., Inc.; Watson Pharmaceuticals, Inc.; Watson Laboratories, Inc.; Watson Pharma, Inc. [read post]
9 Jan 2013, 11:01 pm
Watson Pharmaceuticals, Inc., to address whether and when “reverse payment” agreements made to settle ANDA litigation violate antitrust laws. [read post]
30 Dec 2012, 3:30 am
("Indchemie"), and Torrent Pharmaceuticals Ltd. and Torrent Pharma Inc. [read post]
20 Dec 2012, 12:20 pm
Apotex Corp. is a United States affiliate of the Canadian Company Apotex Inc. [read post]
4 Dec 2012, 6:30 am
("Indchemie"), and Torrent Pharmaceuticals Ltd. and Torrent Pharma Inc. [read post]
30 Nov 2012, 6:00 am
Teva Sues Mylan Over Multiple Sclerosis Drug COPAXONE®Teva Pharmaceutical Industries Ltd. issued a press release last week discussing the abbreviated new drug application (ANDA) containing a Paragraph IV certification for COPAXONE® (glatiramer acetate injection), filed by Mylan Pharmaceuticals Inc. [read post]
30 Nov 2012, 6:00 am
Teva Sues Mylan Over Multiple Sclerosis Drug COPAXONE®Teva Pharmaceutical Industries Ltd. issued a press release last week discussing the abbreviated new drug application (ANDA) containing a Paragraph IV certification for COPAXONE® (glatiramer acetate injection), filed by Mylan Pharmaceuticals Inc. [read post]
26 Nov 2012, 11:00 am
On November 13, 2012, Cumberland Pharmaceuticals Inc. [read post]
19 Nov 2012, 4:00 am
Last week, FDA denied a Citizen Petition filed by Jazz Pharmaceuticals, Inc ("Jazz"). [read post]
18 Oct 2012, 1:00 am
Par Pharmaceutical Inc., the Federal Circuit upheld the district court’s determination that the patents at issue were not invalid as obvious and were infringed by the subject Abbreviated New Drug Applications (ANDAs). [read post]
28 Sep 2012, 11:15 am
Watson Pharmaceuticals, Inc., No. 10-12729, where the Eleventh Circuit upheld reverse payments -- finding no antitrust violation in settlements involving generic Androgel. [read post]
12 Sep 2012, 6:14 pm
IPNews® - Johnson & Johnson unit Janssen Pharmaceuticals Inc. won a major patent infringement victory Tuesday when a New Jersey federal judge held that its patent for the popular birth control drug Ortho Tri-Cyclen Lo is valid. [read post]
12 Sep 2012, 6:08 pm
California -- Johnson & Johnson unit Janssen Pharmaceuticals Inc. was vindicated Tuesday in its efforts to prevent Lupin Pharmaceuticals Inc. from making and marketing a generic version of J&J's popular birth control drug Ortho Tri-Cyclen Lo, as a New Jersey federal judge ruled that the underlying patent is valid. [read post]
11 Sep 2012, 5:30 am
Par Pharmaceutical, Inc., which dealt with whether a drug covered by an Abbreviated New Drug Application (ANDA) infringed the patents owned by that patent owner relative to the proton pump inhibitors (PPI) product omeprazole. [read post]
10 Sep 2012, 7:28 pm
., Glaxo, Inc. v. [read post]
10 Sep 2012, 9:01 am
Galderma Laboratories Inc. v. [read post]
5 Sep 2012, 5:45 pm
California - The Federal Circuit on Tuesday gave Santarus Inc. another chance to prove that its patents for the heartburn drug Zegerid are valid and that Par Pharmaceuticals Inc.'s proposed generic version would infringe those patents. [read post]
5 Sep 2012, 5:26 am
("Intendis") and Dow Pharmaceutical Sciences, Inc. [read post]
4 Sep 2012, 7:04 am
Watson Pharmaceuticals, Inc., No. 10-12729 (11th Cir. [read post]
